Immune Predictive and Prognostic Biomarkers in Immuno-Oncology: Refining the Immunological Landscape of Cancer

1,909
Total downloads
7,199
Total views and downloads

Participate in this topic

Articles

ORIGINAL RESEARCH

Published on 21 Mar 2025

Circadian rhythm related genes identified through tumorigenesis and immune infiltration-guided strategies as predictors of prognosis, immunotherapy response, and candidate drugs in skin cutaneous malignant melanoma

Chengling Liu
Xingchen Liu
Pengjuan Cao
Haiming Xin
Xin Li
Sailing Zhu

doi 10.3389/fimmu.2025.1513750

102 views

ORIGINAL RESEARCH

Published on 20 Mar 2025

Association between oxidative balance score and all-cause and cancer-specific mortality among cancer survivors

Qingmei Gao
Xinfang Zhu
Mengke Chen
Rong Xia
Qi Zhang

doi 10.3389/fimmu.2025.1541675

156 views

BRIEF RESEARCH REPORT

Published on 17 Mar 2025

High tumor CD161 expression predicts a survival advantage and marks a Th1-skewed microenvironment

Briana Amicarella Burns
Manasvi Chandra
Vanaja Konduri
William K. Decker

doi 10.3389/fimmu.2025.1522755

207 views

ORIGINAL RESEARCH

Accepted on 10 Mar 2025

Identification of a novel prognostic marker ADGRG6 in pancreatic adenocarcinoma: multi-omics analysis and experimental validation

Han Wu
Jin Shang
Yuanyan Bao
Huajie Liu
Haoran Zhang
Yaosheng Xiao
Yangtaobo Li
Zhaozhang Huang
Xiaolei Cheng
4 more
Yan-yan Zhan

doi 10.3389/fimmu.2025.1530789

109 views

SYSTEMATIC REVIEW

Published on 26 Feb 2025

Significant association between systemic inflammation response index and prognosis in patients with urological malignancies

Wangbin Ma
Rongqiang Liu
Xinyi Li
Jia Yu
Weixing Wang

doi 10.3389/fimmu.2025.1518647

332 views

ORIGINAL RESEARCH

Published on 13 Feb 2025

A novel classification method for LUAD that guides personalized immunotherapy on the basis of the cross-talk of coagulation- and macrophage-related genes

Zhuoqi Li
Ling Chen
Zhigang Wei
Hongtao Liu
Lu Zhang
Fujing Huang
Xiao Wen
Yuan Tian

doi 10.3389/fimmu.2025.1518102

688 views

ORIGINAL RESEARCH

Published on 30 Jan 2025

Neoadjuvant programmed death ligand-1 with chemotherapy versus chemotherapy alone for limited-stage small-cell lung cancer: a retrospective study

Zhi Yang
Yan-qing Wang
Xiujun Chang

doi 10.3389/fonc.2025.1470445

443 views

ORIGINAL RESEARCH

Published on 29 Jan 2025

SECTM1 acts as an immune-related biomarker of poor prognosis and promotes cancer progression by modulating M2 macrophage polarization in esophageal squamous cell carcinoma

Pengzhou Kong
Ye Jiao
Meng Sun
Zhinan Zhou
Yingying Zhang
Xin Yang
Jing Ren
Mengyuan Yang
Yanyan Dong
Bin Song

doi 10.3389/fimmu.2025.1507227

636 views

ORIGINAL RESEARCH

Published on 06 Jan 2025

The global trends and distribution in tumor-infiltrating lymphocytes over the past 49 years: bibliometric and visualized analysis

Beibei Wu
Ding Luo
Xuejie Wang
Chen Qiao
Rui Li
Jian Liu

doi 10.3389/fimmu.2024.1511866

993 views

ORIGINAL RESEARCH

Published on 17 Dec 2024

First-line pembrolizumab in patients with advanced non-small cell lung cancer and high PD-L1 expression: real-world data from a Spanish multicenter study

Aida Piedra
Sergio Martínez-Recio
Ainhoa Hernández
Teresa Morán
Edurne Arriola
Jordi Recuero-Borau
Manuel Cobo
Patricia Cordeiro
Joaquín Mosquera
12 more
Margarita Majem

doi 10.3389/fonc.2024.1510278

1,030 views

Share on

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Participating Journals

Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- Gynecological Oncology
- 3.5 impact factor
- 6.2 citescore

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

7,199Topic views
4,418Article views
1,909Article downloads

View impact

Articles

Circadian rhythm related genes identified through tumorigenesis and immune infiltration-guided strategies as predictors of prognosis, immunotherapy response, and candidate drugs in skin cutaneous malignant melanoma

Association between oxidative balance score and all-cause and cancer-specific mortality among cancer survivors

High tumor CD161 expression predicts a survival advantage and marks a Th1-skewed microenvironment

Identification of a novel prognostic marker ADGRG6 in pancreatic adenocarcinoma: multi-omics analysis and experimental validation

Significant association between systemic inflammation response index and prognosis in patients with urological malignancies

A novel classification method for LUAD that guides personalized immunotherapy on the basis of the cross-talk of coagulation- and macrophage-related genes

Neoadjuvant programmed death ligand-1 with chemotherapy versus chemotherapy alone for limited-stage small-cell lung cancer: a retrospective study

SECTM1 acts as an immune-related biomarker of poor prognosis and promotes cancer progression by modulating M2 macrophage polarization in esophageal squamous cell carcinoma

The global trends and distribution in tumor-infiltrating lymphocytes over the past 49 years: bibliometric and visualized analysis

First-line pembrolizumab in patients with advanced non-small cell lung cancer and high PD-L1 expression: real-world data from a Spanish multicenter study

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Participating Journals

Frontiers in Oncology

Cancer Immunity and Immunotherapy

Gynecological Oncology